Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Gaush Meditech Ltd. ( (HK:2407) ) is now available.
Gaush Meditech Ltd announced that its subsidiary, Gaush Teleon Ltd, has received a medical device registration certificate in China for its innovative intraocular lens implant system. This system, designed for manual small-incision cataract surgery, reduces surgical incision size, minimizes corneal trauma, and enhances surgical efficiency, addressing the growing demand due to increasing cataract incidence among the aging population in China.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a company incorporated in the Cayman Islands, operating in the medical technology industry. The company, along with its subsidiaries, focuses on developing and providing medical devices, with a particular emphasis on intraocular lens implant systems for cataract surgeries.
Average Trading Volume: 401,356
Technical Sentiment Signal: Sell
Current Market Cap: HK$894.7M
Find detailed analytics on 2407 stock on TipRanks’ Stock Analysis page.